Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definition
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increased pet ownership
3.2.1.2 Advancements in dewormer formulations
3.2.1.3 Increased focus on zoonotic diseases
3.2.1.4 Growing awareness about pet health
3.2.2 Industry pitfalls & challenges
3.2.2.1 Regulatory challenges
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technological landscape
3.6 Future market trends
3.7 Gap analysis
3.8 Porter’s analysis
3.9 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company matrix analysis
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Product Type, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Tablets and chewable treats
5.3 Topical solutions
5.4 Injections
Chapter 6 Market Estimates and Forecast, By Distribution Channel, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Veterinary clinics
6.3 Retail pharmacies
6.4 Online platforms
6.5 Pet stores
Chapter 7 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 North America
7.2.1 U.S.
7.2.2 Canada
7.3 Europe
7.3.1 Germany
7.3.2 UK
7.3.3 France
7.3.4 Italy
7.3.5 Spain
7.3.6 Netherlands
7.3.7 Rest of the Europe
7.4 Asia Pacific
7.4.1 China
7.4.2 Japan
7.4.3 India
7.4.4 Australia
7.4.5 South Korea
7.4.6 Rest of Asia Pacific
7.5 Latin America
7.5.1 Brazil
7.5.2 Mexico
7.5.3 Argentina
7.5.4 Rest of Latin America
7.6 Middle East and Africa
7.6.1 Saudi Arabia
7.6.2 South Africa
7.6.3 UAE
7.6.4 Rest of Middle East and Africa
Chapter 8 Company Profiles
8.1 Bayer AG
8.2 Beaphar
8.3 Bimeda, Inc.
8.4 Boehringer Ingelheim International GmbH
8.5 Ceva Santé Animale
8.6 Durvet Animal Health Products
8.7 Elanco Animal Health Incorporated
8.8 Jurox Pty Limited
8.9 Merck & Co., Inc.
8.10 Ourofino Animal Health
8.11 PetIQ, LLC.
8.12 Sava Healthcare Limited
8.13 Vetoquinol
8.14 Virbac SA
8.15 Zoetis Inc.
